Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients
ConclusionsOur present study suggests that 120-minutes postload plasma glucose and PEDF values may be markers and potential therapeutic targets of coronary artery inflammation in type 2 diabetic patients.Clinical Trial RegistrationURL:http://clinicaltrials.gov. Unique identifier: NCT00722631.Graphic AbstractNew markers for diabetes and CAD is on the horizon! Two-hour postload plasma glucose and pigment epithelium derived factor are markers of coronary artery inflammation in type 2 diabetic patients.
Source: Journal of Nuclear Cardiology - Category: Nuclear Medicine Source Type: research
More News: Actos | Aspirin | Cardiology | Chemistry | Cholesterol | Clinical Trials | CT Scan | Diabetes | Diabetes Type 2 | Endocrinology | Glimepiride | Heart | Insulin | Nuclear Medicine | PET Scan | Study